BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
|
|
- Ariel Tate
- 6 years ago
- Views:
Transcription
1 BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) April 2014 Review April 2017 Bulletin 197: Dapoxetine for Premature Ejaculation JPC Recommendations: To support the East of England Priorities Advisory Committee (PAC) policy statement and recommendations as outlined below:- The commissioning of dapoxetine is low priority and is not recommended. N:\Medicines Management\JPC\Approved Bulletins and Papers\Approved bulletins & papers (from Aug 13 )\April 14\Dapoxetine for Premature Ejaculation - Bulletin 197.docx
2 GUIDANCE STATEMENT The East of England Priorities Advisory Committee A function of the Programme Dapoxetine (Priligy) for premature ejaculation (PE) PAC recommendations The commissioning of dapoxetine is low priority and is not recommended. Background information Selective Serotonin Reuptake Inhibitors [SSRIs (e.g. paroxetine, fluoxetine, fluvoxamine, sertraline, clomipramine)] have beneficial effects on premature ejeculation (PE). They are used off-label as first-line treatment for this condition and their effectiveness is often maintained for several years. 2 Dapoxetine is a more potent SSRI and is the first licensed treatment for PE in men aged years of age. The time to maximum serum concentration of dapoxetine is about 1-2 hours and it is rapidly eliminated, with a half-life of 1.5 hours. 1 This allows for on-demand treatment, i.e. taken as needed 1-3 hours prior to sexual activity. Dapoxetine is the only drug with this dosing schedule. 1,2 The British Association of Urological Surgeons state that: PE is usually lifelong (i.e. it usually dates back to the first sexual experience). Rarely, PE may develop in later life when it is often progressive. We do not know accurately how common it is but between 1 in 3 and 1 in 5 men (20-30%) are thought to have PE. Less than a quarter of men with PE actually seek medical advice for their condition. Evidence PE is often associated with erectile dysfunction (impotence) and with rapid loss of erection after ejaculation. 2 In 5 studies, men had to meet the diagnostic criteria for PE as specified in the Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM-IV-TR): the onset of orgasm and ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wished, in most intercourse episodes, in the 6 months before enrolment, and marked distress or interpersonal difficultly due to PE. Men were enrolled if they had been in a stable monogamous, heterosexual relationship for 6 months and had an intravaginal ejaculatory latency time (IELT) of 2 minutes in at least 75% of intercourse episodes at baseline in four of the studies. 3-5 Exclusion criteria included erectile dysfunction, concomitant use of SSRIs or tricyclic antidepre ssants, major psychiatric disorders, history of medical illness, uncontrolled hypertensions or other forms of sexual dysfunction. This is an NHS document not to be used for commercial or marketing purposes 1 of 5
3 PAC: Dapoxetine (Priligy) for premature ejaculation (PE) v1 Dapoxetine was taken 1-3 hours prior to anticipated sexual intercourse, and not more than once every 24 hours. The primary endpoint of four of the phase 3 studies was average IELT, measured using a stopwatch by participants /partners. 3-5 In the fifth study, the primary endpoint was evaluation of potential withdrawal effects. 6 Mean baseline IELT times were minute. 3-5 The following four studies evaluated the efficacy and safety of dapoxetine. Studies NCT and NCT (integrated analysis). 3 Men aged 18 to 65 years with PE (mean duration 10 years) were randomised to 12 weeks of treatment with dapoxetine 30mg (n=874) or 60mg (n=870) or placebo (n=870) and instructed to have sexual intercourse six or more times per month. Stratification was according to IELT: 1 minute or >1 minute. A sample size of 300 patients per group was deemed sufficient to detect a 1 minute difference in IELT between the best performing and worst performing treatments with 98% power. Of the 2,614 men enrolled, 75% completed the study. Few patients (1%) discontinued due to lack of efficacy.» The primary endpoint, mean IELT at week 12, was increased 3-4-fold with dapoxetine and to a greater extent than placebo with endpoint values of: 2.78 minutes (30mg) and 3.32 minutes (60mg), vs minutes (placebo) (p<0.0001, both doses vs. placebo and p=0.0007, 60mg vs. 30mg). Dapoxetine was better than placebo from the first dose. Even though patients were instructed to take dapoxetine 1-3 hours before anticipated sexual intercourse, not all reported events were inside this time window, but even when taken 30 mins -1 hour before, or more than 3 hours before, IELT was still significantly increased with both doses of dapoxetine vs. placebo. Study NCT Men (mean age 40 years) were randomised to 24-weeks of treatment with placebo (n=385), dapoxetine 30mg (n=388) or 60mg (n=389). Most (92%) men enrolled had poor or very poor perceived control over ejaculation, with PE causing extreme personal distress in 68%, and little or no interpersonal difficulties in just under half (49%). A sample size of 258 patients per group was deemed sufficient to detect a 1 minute difference in IELT between placebo and dapoxetine 60mg with 90% power. Stratification was according to IELT: 1 minute or 0.5 minutes. Of the 1,162 men enrolled, 53% completed the study. Analysis was in the intention-to-treat population.» The primary endpoint, mean IELT at week 24, increased significantly with dapoxetine to 3.1 minutes (30mg) and 3.5 minutes (60mg) vs. 1.9 minutes (placebo), (p<0.001 both doses vs. placebo). Mean IELT improvements were also significantly greater with both doses of dapoxetine in men with baseline IELT 1 min and 0.5min. NCT (Asia-Pacific study). 5 Men were randomised to 12 weeks of treatment with placebo (n=357) or dapoxetine 30mg (n=354) or 60mg (n=356). Most (89%) men enrolled had poor or very poor perceived control over ejaculation, with PE causing moderate-extreme personal distress in 68%, and moderate extreme interpersonal difficulties in 80%. Stratification was according to IELT: 1 minute or >1 minute. Of the 1,067 men enrolled, 80% completed the study. The most common reasons for discontinuation in 11.6% were personal reasons, insufficient response or other reasons. Few patients discontinued due to lack of efficacy (1.1%). No power or sample size calculation was stated.» The primary endpoint, mean IELT at 12 weeks, increased significantly with dapoxetine 30mg (3.9 minutes) and 60mg (4.2 minutes) compared with placebo (2.4 minutes), (p<0.001 both doses vs. placebo). Significant mean IELT increases were seen in men with baseline IELT 1 minute with both doses of dapoxetine, but only with the 30mg dose in men with baseline IELT 0.5 minutes. This is an NHS document not to be used for commercial or marketing purposes 2 of 5
4 PAC: Dapoxetine (Priligy) for premature ejaculation (PE) v1 The primary endpoint of study NCT was the evaluation of potential withdrawal effects after abrupt discontinuation. Men (n=1238) were randomised to treatment with placebo, dapoxetine 60mg as needed + placebo once daily or dapoxetine once daily + placebo as needed for 9 weeks. 6 Patients were expected to attempt sexual intercourse at least six times a month. At the end of the double-blind phase, men taking dapoxetine were rerandomised in a double-blind fashion to take the same treatment or switch to placebo for an additional 7 days in order to assess withdrawal symptoms. Other endpoints were the treatment benefits of dapoxetine vs. placebo, based on patient reported outcomes. 6 All efficacy analyses were based on the modified ITT population; patients who took?1 doses of study drug and answered either or both of the perceived control and satisfaction patient-reported outcome (PRO) questions at baseline and at?1 sample times after baseline. No power or sample size calculation was stated. Results are summarised in the Patient reported outcomes section below. Patient reported outcomes There were a number of patient reported outcomes in all of the studies. Improvements were seen with dapoxetine treatment from the first study visit (4 weeks in all studies). Perceived control over ejaculation: In the integrated analysis, control over ejaculation improved in all three groups with no significant differences between placebo and dapoxetine. 3 In the other studies, significant improvements with control over ejaculation were seen with dapoxetine compared with placebo (p<0.001). 4-6 Satisfaction with sexual intercourse: In the integrated analysis, satisfaction improved in all three groups with no significant differences between placebo and dapoxetine and approximately three-quarters of partners of those using dapoxetine reported fair, good, very good satisfaction with sexual intercourse at end of study, compared with just over half of those using placebo. 3 In the other studies, significant improvements with sexual intercourse were seen with dapoxetine compared with placebo (p<0.001). 4-6 Personal distress related to ejaculation: Improvements in distress were significantly better with dapoxetine at most time points, including week 24 (p<0.001). 4-6 Interpersonal difficulties related to ejaculation: Improvements in interpersonal difficulty were significantly better with dapoxetine at most time points, including week 24 (p<0.05). 4-6 Change in patients perception of PE: Severity rating of PE improved with dapoxetine treatment in the integrated analysis, with PE rated as none/mild by 12% taking placebo and 27% and 34% taking dapoxetine 30mg and 60mg respectively (p< vs. placebo). 3 In the other studies, significantly higher proportions of men using dapoxetine (30.6%-41.5%) reported that their PE was better or much better than with placebo (15.6%-22%). 4,5 In study NCT , more men met the composite PRO definition of clinical benefit with dapoxetine than placebo at weeks 12 and 24 (p<0.001): this corresponds with improvements in IELT, satisfaction and the man s perception of his condition. 4 In the Asia-Pacific study, significantly more men treated with dapoxetine met the composite PRO-defined level of clinical benefit (p<0.001) and the mean IELT achieved by these men, regardless of treatment group, was 5.4 minutes. 5 Safety The safety of dapoxetine was evaluated in 4224 subjects with premature ejaculation who participated in five double blind, placebo controlled clinical trials. Of the 4224 subjects, 1616 received dapoxetine 30 mg as needed and 2608 received 60 mg, either as needed or once daily. 1 Adverse effects: The most common side effects, occurring in?1/10 patients, were headache, dizziness and nausea. Syncope has been reported in clinical trials and is considered medicine- This is an NHS document not to be used for commercial or marketing purposes 3 of 5
5 PAC: Dapoxetine (Priligy) for premature ejaculation (PE) v1 related. Most cases occurred within the first 3 hours after doses, after the first dose or associated with study-related procedures in the clinical setting (such as blood tests or blood pressure measurements). 1 Withdrawal: Abrupt discontinuation of chronically administered SSRIs used to treat chronic depressive disorders has been reported to result in the following symptoms: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paraesthesias such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia and hypomania. A double blind clinical trial in subjects with PE designed to assess the withdrawal effects of 62 days of daily or as needed dosing with 60mg dapoxetine showed mild withdrawal symptoms with a slightly higher incidence of insomnia and dizziness in subjects switched to placebo after daily dosing. 1 Cost 7 Commonly used SSRIs to treat PE are paroxetine, sertraline and fluoxetine, which must be taken on a daily basis. Drug and dose Cost per pack Cost per year Fluoxetine, 20-60mg/day [off-label indication] 30 x 20mg capsules = (20-60mg capsules/ day) Paroxetine, 20-40mg/day [off-label indication] 30 x 20mg tablets = Sertraline, mg/day [off-label indication] 28 x 50mg tablets = x 100mg tablets = Dapoxetine, 30-60mg prn 3 x 30mg = x 30mg = x 60mg = x 60mg = Based on six attempts a month (as per study requirements): (30mg prn) to ~ 400 (60mg, but initiating with 30mg). Document history PAC approval date 3 March 2014 Version 1 Consultation process QA process PAC members Katie Smith Director of East Anglia Medicines Information Service. This is an NHS document not to be used for commercial or marketing purposes 4 of 5
6 References PAC: Dapoxetine (Priligy) for premature ejaculation (PE) v1 1. Summary of Product Characteristics Priligy 30mg and 60mg film-coated tablets. A.Menarini Farmaceutica Internazionale SRL. Date of revision of the text: 26 February The British Association of Urological Surgeons. Information for patients. Accessed 16th February Pryor JL, Althof SE, Steidle C et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised, controlled trials. Lancet 2006; 368(9539): Buvat J, Tesfaye F, Rothman M et al. Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009; doi: /j.eururo McMahon C, Kim SW, Park NC et al. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010; 7: Kaufman JM, Rosen RC, Mudumbi RV et al. Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial. BJU Int 2008; 103: Dapoxetine (Priligy ) for premature ejaculation, London New Drugs Group/London Medicines Evaluation Network Review. November finalnov2013.pdf Acknowledgement The evidence and patient reported outcomes are based on dapoxetine review by London New Drugs Group/London Medicines Evaluation Network. 7 This is an NHS document not to be used for commercial or marketing purposes 5 of 5
London Medicines Evaluation Network Review. Dapoxetine (Priligy ) for premature ejaculation Updated January 2014
London Medicines Evaluation Network Review Dapoxetine (Priligy ) for premature ejaculation Updated January 2014 Summary Dapoxetine is the first oral treatment for premature ejaculation (PE) to be licensed
More informationNew Medicine Assessment
New Medicine Assessment Dapoxetine (Priligy ) Treatment of premature ejaculation (PE) in men 18 to 64 years of age Recommendation: Rag Status BLACK Dapoxetine (Priligy) is not recommended for the treatment
More informationPatient Information 4472/PRI/FEB/2013/STH Date of preparation: June 2013
Patient Information 4472/PRI/FEB/2013/STH Date of preparation: June 2013 A patient s guide to treating Premature Ejaculation with PRILIGY (dapoxetine) It is human nature to have questions when we come
More informationSex Therapy for PE is Necessary
Sex Therapy for PE is Necessary Stanley E. Althof, Ph.D. Executive Director Center for Marital and Sexual Health of South Florida Professor Emeritus Case Western Reserve University School of Medicine Disclosures
More informationSCIENTIFIC CONCLUSIONS AND GROUNDS FOR POSITIVE OPINION AND AMENDMENT OF THE LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EUROPEAN MEDICINES AGENCY
ANNEX II SCIENTIFIC CONCLUSIONS AND GROUNDS FOR POSITIVE OPINION AND AMENDMENT OF THE LABELLING AND PACKAGE LEAFLET PRESENTED BY THE EUROPEAN MEDICINES AGENCY 14 Scientific conclusions Overall summary
More informationQuick Reference Guide to PE
International Society for Sexual Medicine Quick Reference Guide to PE Version 1, October 2010 www.issm.info What is PE? Definition Several definitions for PE exist but most are not evidenced-based, lack
More informationDapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries
european urology 55 (2009) 957 968 available at www.sciencedirect.com journal homepage: www.europeanurology.com Sexual Medicine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind,
More informationAPPROPRIATE USE GUIDE
APPROPRIATE USE GUIDE PRILIGY is indicated for the treatment of premature ejaculation in adult men aged 18 to 64 years 1 * PRILIGY should only be prescribed to patients who meet all the following criteria:
More informationPharmacokinetic and pharmacodynamic features of dapoxetine, a novel drug for on-demand treatment of premature ejaculation
Mini rev Article PHARMACOKINETIC AND PHARMACODYNAMIC FEATURES OF DAPOXETINE FOR PE ANDERSSON et al. Associate Editor Michael G. Wyllie Editorial Board Ian Eardley, UK Jean Fourcroy, USA Sidney Glina, Brazil
More informationPatient reported outcomes in the assessment of premature ejaculation
Review Article Patient reported outcomes in the assessment of premature ejaculation Stanley E. Althof 1,2 1 Center for Marital and Sexual Health of South Florida, West Palm Beach, FL 33401, USA; 2 Case
More informationThe Impact of Premature Ejaculation on Partners and Relationships
available at www.sciencedirect.com journal homepage: www.europeanurology.com The Impact of Premature Ejaculation on Partners and Relationships Tricia Barnes * 90 Harley Street, London W1G 7HS, United Kingdom
More informationNew Medicine Review. Treatment of primary premature ejaculation in adult men
April 2019 New Medicine Review Fortacin (Lidocaine / Prilocaine) Spray Treatment of primary premature ejaculation in adult men Recommendation: Rag Status BLACK Fortacin (Lidocaine / Prilocaine) is not
More informationASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION
ASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION Dr Michael Gillman St Andrews Hospital Wickham Terrace Spring Hill Mater Private Clinic, South Brisbane Shore St West Medical Centre, Cleveland
More informationIdentifying and treating premature ejaculation: Importance of the sexual history
RICHARD E. PAYNE, MD* Clinical Instructor, Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA Private Practice, North Coast Family Medical Group, Encinitas,
More informationImpact of Premature Ejaculation: The Psychological, Quality of Life, and Sexual Relationship Consequences
1 Impact of Premature Ejaculation: The Psychological, Quality of Life, and Sexual Relationship Consequences Raymond C. Rosen, PhD,* and Stanley Althof, PhD *New England Research Institutes, Watertown,
More informationEjaculation. Ege Can Serefoglu, MD, FECSM Bagcilar Training & Research Hospital, Istanbul
+ Ejaculation Ege Can Serefoglu, MD, FECSM Bagcilar Training & Research Hospital, Istanbul + Lectures Master lecture 1 - Delayed ejaculation/anorgasmia Emmanuele Jannini (Italy) Taxonomy of ejaculatory
More informationavanafil 50mg, 100mg, 200mg tablets (Spedra ) SMC No. (980/14) A. Menarini Farmaceutica Internazionale SRL.
avanafil 50mg, 100mg, 200mg tablets (Spedra ) SMC No. (980/14) A. Menarini Farmaceutica Internazionale SRL. 07 August 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above
More informationIMPORTANT INFORMATION
IMPORTANT INFORMATION A patient s guide to treating Premature Ejaculation with PRILIGY (dapoxetine) This guide is intended only for patients who have been prescribed Priligy by their Physician. If you
More informationW. Wallace Dinsmore and Michael G. Wyllie Royal Victoria Hospital, Belfast, and Plethora Solutions Ltd, London, UK
. JOURNAL COMPILATION 29 BJU INTERNATIONAL Sexual Medicine, EJACULATORY LATENCY, CONTROL AND SEXUAL SATISFACTION IN MEN WITH PE DINSMORE and WYLLIE BJUI BJU INTERNATIONAL improves ejaculatory latency,
More informationScottish Medicines Consortium
Scottish Medicines Consortium escitalopram, 5mg, 10mg, and 20mg tablets and 10mg/ml oral drops (Cipralex) No. (406/07) Lundbeck Ltd 7 September 2007 The Scottish Medicines Consortium has completed its
More informationERECTILE DYSFUNCTION PREMATURE EJACULATION. David Goldmeier
ERECTILE DYSFUNCTION PREMATURE EJACULATION David Goldmeier d.goldmeier@nhs.net LEARNING OBJECTIVES Management of erectile dysfunction and premature ejaculation in General Practice Discussion and consideration
More informationReviews/Evaluations. Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients. Pharmacotherapeutic Options
Reviews/Evaluations Use of Selective Serotonin Reuptake Inhibitors in Pediatric Patients Childhood major depressive disorder (MDD) has become recognized as a serious and common illness affecting between
More informationClinical Study Synopsis
Clinical Study Synopsis This Clinical Study Synopsis is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research. This document is not intended to replace
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationGREATER MANCHESTER INTERFACE PRESCRIBING GROUP
GREATER MANCHESTER INTERFACE PRESCRIBING GROUP On behalf of the GREATER MANCHESTER MEDICINES MANAGEMENT GROUP SHARED CARE GUIDELINE FOR THE PRESCRIBING OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE. Opinion. 1 October 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 1 October 2008 EFFEXOR SR 37.5 mg prolonged-release capsule B/30 (CIP: 346 563-3) EFFEXOR SR 75 mg prolonged-release
More informationM. Abu El-Hamd A. Abdelhamed. Summary 1 INTRODUCTION ORIGINAL ARTICLE
Accepted: 6 February 2017 DOI: 10.1111/and.12829 ORIGINAL ARTICLE Comparison of the clinical efficacy and safety of the on- demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationThe European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking Behavior
available at www.sciencedirect.com journal homepage: www.europeanurology.com The European Online Sexual Survey (EOSS): Pan-European Perspectives on the Impact of Premature Ejaculation and Treatment-Seeking
More informationClinical Trial Study Synopsis
Clinical Trial Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency
More informationClinical Trial Study Synopsis
Clinical Trial Study Synopsis This file is posted on the Bayer HealthCare Clinical Trials Registry and Results website and is provided for patients and healthcare professionals to increase the transparency
More informationThe clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.
The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. Please note that the results reported in any single trial may not reflect the overall
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationPFIZER INC. THERAPEUTIC AREA AND FDA APPROVED INDICATIONS: See United States Package Insert (USPI)
PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.
More informationPrevious Study Return to List Next Study
A service of the U.S. National Institutes of Health Trial record 1 of 1 for: 42603ATT3013 Previous Study Return to List Next Study A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS
More informationBRL /RSD-101C0D/1/CPMS-704. Report Synopsis
Report Synopsis Study Title: A Randomized, Multicenter, 10-Week, Double-Blind, Placebo- Controlled, Flexible-Dose Study to Evaluate the Efficacy and Safety of Paroxetine in Children and Adolescents with
More informationDepartment of Urology, Polytechnic University of Marche, Ancona, Italy
European Review for Medical and Pharmacological Sciences 2017; 21: 1036-1040 A randomized single-center study to compare the efficacy and tolerability of tadalafil once daily plus lidocaine anesthetic
More informationISSM PATIENT INFORMATION SHEET ON PREMATURE EJACULATION
International Society for Sexual Medicine - www.issm.info ISSM PATIENT INFORMATION SHEET ON PREMATURE EJACULATION Version: January 2015 Premature Ejaculation Advice for Men from the International Society
More informationStudy No: Title: Rationale: . Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationPremature ejaculation: a clinical update
Premature ejaculation: a clinical update Neil R Palmer and Bronwyn G A Stuckey Since the late 1990s, when phosphodiesterase type 5 (PDE5) inhibitors became available for the treatment of erectile dysfunction
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationVolume 4; Number 5 May 2010
Volume 4; Number 5 May 2010 CLINICAL GUIDELINES FOR ANTIDEPRESSANT USE IN PRIMARY AND SECONDARY CARE Lincolnshire Partnership Foundation Trust in conjunction with Lincolnshire PACEF have recently updated
More informationSwitching Tramacet to paracetamol alone or paracetamol and codeine
Bulletin 62 February 2014 Community Interest Company Switching Tramacet to paracetamol alone or paracetamol and codeine This is one of a number of bulletins providing further information on medicines contained
More informationDiagnosis and Treatment of Premature Ejaculation by Urologists in South Korea
pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2016 December 34(3): 217-223 https://doi.org/10.5534/wjmh.2016.34.3.217 Original Article Diagnosis and Treatment of Premature Ejaculation by Urologists
More informationsodium oxybate, 500mg/ml oral solution (Xyrem) No. (246/06) UCB Pharma Ltd
Scottish Medicines Consortium Resubmission sodium oxybate, 500mg/ml oral solution (Xyrem) No. (246/06) UCB Pharma Ltd 10 August 2007 The Scottish Medicines Consortium has completed its assessment of the
More informationAntidepressants (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors) in children 6-12 years of age with depressive episode/disorder
updated 2012 Antidepressants (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors) in children 6-12 years of age with depressive episode/disorder Q10: Are antidepressants (Tricyclic antidepressants
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
Study No.: 29060/717 Title: A Double-Blind, Placebo-Controlled, 3-Arm, Fixed-Dose Study of CR Intermittent Dosing (12.5 mg and 25 mg) for Premenstrual Dysphoric Disorder Rationale: In most trials investigating
More informationPremature Ejaculation: An Observational Study of Men and Their Partners
Blackwell Science, LtdOxford, UKJSMJournal of Sexual Medicine1743-6095Journal of Sexual Medicine 2005 200523358367Original ArticlePremature Ejaculation: An Observational StudyPatrick et al. 358 ORIGINAL
More informationManagement of SSRI Induced Sexual Dysfunction. Serotonin Reuptake Inhibitors*
Management of SSRI Induced Sexual Dysfunction John J. Miller, M.D. Medical Director, Center for Health and WellBeing Exeter, NH Serotonin Reuptake Inhibitors* fluoxetine clomipramine sertraline paroxetine
More informationStudie 083 (950E-CNS )
Studie 083 (950E-CNS-0005-083) Studienberichtssynopse Clinical Study Report 950E-CNS-0005-083 EFFECTS OF THE USE OF REBOXETINE AS A SUBSTITUTE FOR SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTIDEPRESSANTS
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) Sept 2015 Review: Sept 2018 Bulletin 227: EXOGEN ultrasound bone healing system used for the management of long bone fractures JPC Recommendations:
More informationMedical and Behavioral Health: A Delicate Balance
Medical and Behavioral Health: A Delicate Balance Mae Centeno DNP, RN, CCRN,CCNS,ACNS-BC Corporate Director Chronic Care Continuum Jeff Place MSN,MBA,RN Director BUMC Nursing Service Support 1 Background
More informationPRILIGY. (dapoxetine hydrochloride)
PRILIGY (dapoxetine hydrochloride) SYNCOPE: Patients on PRILIGY need to be made aware that they could experience syncope at any time with or without prodromal symptoms during their treatment with PRILIGY.
More informationDepression in Pregnancy
TREATING THE MOTHER PROTECTING THE UNBORN A MOTHERISK Educational Program The content of this program reflects the expression of a consensus on emerging clinical and scientific advances as of the date
More informationNorpramin (desipramine)
Generic name: Desipramine Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets Available in generic: Yes Drug class: Tricyclic antidepressant General Information Norpramin (desipramine)
More informationA prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation
international journal of andrology ISSN 0105-6263 ORIGINAL ARTICLE A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation A.
More informationPremature ejaculation: A clinical review for the general physician
CLINICAL Premature : A clinical review for the general physician Eric Chung, Brent Gilbert, Marlon Perera, Matthew J Roberts Background Premature is one of the most common sexual dysfunctions in men. Recent
More informationPamelor (nortriptyline)
Generic name: Nortriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg capsules; 10 mg/5 ml oral solution Available in generic: Yes Drug class: Tricyclic antidepressant General Information Pamelor
More informationPremature Ejaculation
Premature Ejaculation Patient Information Urology Department Author ID: PH Leaflet Number: Urol 014 Version: 4 Name of Leaflet: Premature Ejaculation Date Produced: November 2016 Review Date: November
More informationThe Effectiveness of Tramadol in Treatment of Premature Ejaculation on-demand Basis
TREATMENT THE IRAQI POSTGRADUATE OF PREMATURE MEDICAL EJACULATION JOURNAL VOL.12, NO 2,2013 The Effectiveness of Tramadol in Treatment of Premature Ejaculation on-demand Basis Montadhar H. Nima*, Samir
More informationPSYCHOTROPIC MEDICATION AND THE WORKPLACE. Dr. Marty Ewer 295 Fullarton Road Parkside
PSYCHOTROPIC MEDICATION AND THE WORKPLACE Dr. Marty Ewer 295 Fullarton Road Parkside 5063 82999281 Introduction Depression and anxiety commonly occur in people who work. The World Health Organization has
More informationSalvage Use of Citalopram for Treatment of Fluoxetine-Resistant Premature Ejaculation in Recently Married Men A Prospective Clinical Trial
Sexual Dysfunction and Infertility Salvage Use of Citalopram for of Fluoxetine-Resistant Premature Ejaculation in Recently Married Men A Prospective Clinical Trial Mohammad Reza Dadfar, 1 Mahmood Reza
More informationDetection of hagar el sada and comparing it with others treatment
Detection of hagar el sada and comparing it with others treatment Introduction Premature ejaculation (PE) refers to the persistent or recurrent discharge of semen with minimal sexual stimulation before,
More information5 COMMON QUESTIONS WHEN TREATING DEPRESSION
5 COMMON QUESTIONS WHEN TREATING DEPRESSION Do Antidepressants Increase the Possibility of Suicide? Will I Accidentally Induce Mania if I Prescribe an SSRI? Are Depression Medications Safe and Effective
More informationHow Does Premature Ejaculation Impact a Man s Life?
Journal of Sex & Marital Therapy ISSN: 0092-623X (Print) 1521-0715 (Online) Journal homepage: http://www.tandfonline.com/loi/usmt20 How Does Premature Ejaculation Impact a Man s Life? T. SYMONDS, D. ROBLIN,
More informationComparison of Alpha Blockers in Treatment of Premature Ejaculation: A Pilot Clinical Trial
Iranian Red Crescent Medical Journal. 2013 October; 15(10): e13805. Published Online 2013 October 05. DOI: 10.5812.ircmj.13805 Research Article Comparison of Alpha Blockers in Treatment of Premature Ejaculation:
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE. Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE September 2012 Review date: September 2014 Bulletin 169: Daily Tadalafil (Cialis ) for penile rehabilitation following radical prostactectomy JPC Recommendation:
More informationPRILIGY 30 mg and 60 mg Janssen
30 mg and 60 mg Janssen dapoxetine hydrochloride NAME OF THE MEDICINAL PRODUCT (dapoxetine hydrochloride) QUALITATIVE AND QUANTITATIVE COMPOSITION Each 30 mg film-coated tablet contains 30 mg of dapoxetine
More informationANTI-DEPRESSANT MEDICATIONS
ANTI-DEPRESSANT MEDICATIONS This information is not intended to be a substitute for medical advice. It s purpose is solely informative. If your client or yourself are taking antidepressants, do not change
More informationTRANSPARENCY COMMITTEE OPINION. 21 October 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 October 2009 TEMERIT DUO 5 mg/12.5 mg, film-coated tablets Pack of 30 (CIP: 393 976-9) Pack of 90 (CIP: 393 977-5)
More informationPFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.
Public Disclosure Synopsis Protocol A7772 September 25 Final PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert.
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centers Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationAccepted Manuscript. Title: Current therapies for premature ejaculation. Author: Serap Gur Philip J. Kadowitz Suresh C. Sikka S (16)
Accepted Manuscript Title: Current therapies for premature ejaculation Author: Serap Gur Philip J. Kadowitz Suresh C. Sikka PII: S1359-6446(16)30154-4 DOI: http://dx.doi.org/doi:10.1016/j.drudis.2016.05.004
More informationClinical Policy: Clomipramine (Anafranil) Reference Number: HIM.PA.149 Effective Date: Last Review Date: 05.18
Clinical Policy: (Anafranil) Reference Number: HIM.PA.149 Effective Date: 03.13.18 Last Review Date: 05.18 Line of Business: HIM Revision Log See Important Reminder at the end of this policy for important
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Each film coated tablet contains dapoxetine hydrochloride equivalent to 30 mg or 60 mg dapoxetine.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Priligy 30 mg film coated tablets Priligy 60 mg film coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet
More informationUrology Nephrology Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran
(2006) 18, 164 169 & 2006 Nature Publishing Group All rights reserved 0955-9930/06 $30.00 www.nature.com/ijir ORIGINAL ARTICLE Safety and efficacy of citalopram in the treatment of premature ejaculation:
More informationTofranil and Tofranil-PM (imipramine)
Tofranil and Tofranil-PM (imipramine) Generic name: Imipramine Available strengths: 10 mg, 25 mg, 50 mg tablets; 75 mg, 100 mg, 125 mg, 150 mg capsules (Tofranil-PM) Available in generic: Yes Drug class:
More informationElavil (amitriptyline)
Generic name: Amitriptyline Available strengths: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg tablets; 10 mg/ml injection Available in generic: Yes Drug class: Tricyclic antidepressant General Information
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Priligy 30 mg film coated tablets Priligy 60 mg film coated tablets dapoxetine
PACKAGE LEAFLET: INFORMATION FOR THE USER Priligy 30 mg film coated tablets Priligy 60 mg film coated tablets dapoxetine Read all of this leaflet carefully before you start taking this medicine. Keep this
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationEAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation
EAU GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation (Partial text update March 2015) K. Hatzimouratidis (Chair), F. Giuliano, I. Moncada, A. Muneer, A. Salonia (Vice-chair),
More informationED treatments: PDE5 inhibitors, injections and vacuum devices
ED treatments: PDE5 inhibitors, injections and vacuum devices Martin Steggall Clinical Nurse Specialist (Erectile Dysfunction and Premature Ejaculation) Barts Health NHS Trust; Associate Dean, Director
More informationBRL /RSD-101C0F/1/CPMS-716. Report Synopsis
Report Synopsis Study Title: A Multicenter, Open-label, Six-Month Extension Study to Assess the Long-Term Safety of Paroxetine in Children and Adolescents with Major Depressive Disorder (MDD) or Obsessive-Compulsive
More informationPremature Ejaculation
Understanding & Treating Premature Ejaculation David L. Rowland, PhD Peggy Rose, RN, MSN, CNS-BC, FNP-BC R ecent advances in sexual health have placed significant focus on erectile dysfunction (ED). Defined
More informationGUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation
GUIDELINES ON MALE SEXUAL DYSFUNCTION: Erectile Dysfunction and Premature Ejaculation (Text update March 2009) E. Wespes, E. Amar, I. Eardley, F. Giuliano, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi,
More informationAustralian Centre for Sexual Health, Sydney, NSW, Australia. Corresponding author
Clinical Medicine Insights: Reproductive Health Review Open Access Full open access to this and thousands of other papers at http://www.la-press.com. Efficacy of Dapoxetine in the Treatment of Premature
More informationEffects of Tamsulosin on Premature Ejaculation in Men with Benign Prostatic Hyperplasia
pissn: 2287-4208 / eissn: 2287-4690 World J Mens Health 2014 August 32(2): 99-104 http://dx.doi.org/10.5534/wjmh.2014.32.2.99 Original Article Effects of Tamsulosin on Premature Ejaculation in Men with
More informationClinical Trial Synopsis
Clinical Trial Synopsis Title of Study: A Phase III, Open-Label, Fixed-Dose Study to Determine the Safety of Long-Term Administration of TAK-375 in Subjects With Chronic Insomnia Protocol Number: Name
More informationAcknowledgements and Disclaimers: AUA Guideline on the Management of Premature Ejaculation (PE)
Acknowledgements and Disclaimers: AUA Guideline on the Management of Premature Ejaculation (PE) This document was written by the Erectile Dysfunction Guideline Update Panel of the American Urological Association
More informationThe Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability
The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability Danielle Adams Principal Clinical Pharmacist Pharmacy and Medicines Optimisation Team HPFT July 2017 1
More informationMale Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: gmail.
RESEARCH ARTICLE Open Access Male Sexual Dysfunction in Psychiatric Illnesses Sujit Kumar Kar 1, Saranya Dhanasekaran 1 Correspondence: drsujita@gmail.com; saranya296@ gmail.com Full list of author information
More informationL eiaculazione precoce. Giovanni Corona MD, PhD Endocrinology Unit Medical Department, Ospedale Maggiore Bologna, Italy
L eiaculazione precoce Giovanni Corona MD, PhD Endocrinology Unit Medical Department, Ospedale Maggiore Bologna, Italy jocorona@libero.it Corona et al., Nat Rew Urol 2012;9:508 ... ejaculation which always
More informationNeuropathic Pain Treatment Guidelines
Neuropathic Pain Treatment Guidelines Background Pain is an unpleasant sensory and emotional experience that can have a significant impact on a person s quality of life, general health, psychological health,
More informationORIGINAL PAPER. Summary. Salvatore Sansalone 1, Giorgio Ivan Russo 2, Nicola Mondaini 3, Francesco Cantiello 4, Gabriele Antonini 5, Tommaso Cai 6
ORIGINAL PAPER DOI: 10.4081/aiua.2016.3.171 A combination of tryptophan, Satureja montana, Tribulus terrestris, Phyllanthus emblica extracts is able to improve sexual quality of life in patient with premature
More informationIC351 (tadalafil, Cialis): update on clinical experience
(2002) 14, Suppl 1, S57 S64 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir IC351 (tadalafil, Cialis): update on clinical experience 1 * 1 Urological practice,
More informationREVIEWS The Authors. Sexual Medicine published by Wiley Periodicals, Inc.
REVIEWS An Evidence-Based Unified Definition of Lifelong and Acquired Premature Ejaculation: Report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSummary ID#7029. Clinical Study Summary: Study F1D-MC-HGKQ
CT Registry ID# 7029 Page 1 Summary ID#7029 Clinical Study Summary: Study F1D-MC-HGKQ Clinical Study Report: Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar
More informationInternational Society for Sexual Medicine s Guidelines for the Diagnosis and Treatment of Premature Ejaculationjsm_
2947 REPORTS International Society for Sexual Medicine s Guidelines for the Diagnosis and Treatment of Premature Ejaculationjsm_1975 2947..2969 Stanley E. Althof, PhD, 1 Carmita H.N. Abdo, MD, PhD, 2 John
More information